Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M López
Observed names:
M LOPEZ,
M Lopez,
M. Lopez
Institution:
Instituto Nazionale Tumori Regina Elena
Observed institutions:
University of Verona,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Istituti di Ricovero e Cura a Carattere Scientifico,
Instituto Nazionale Tumori Regina Elena
OpenAlex ID:
A5111948408
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
1988
·
G Ambrosini
, M Balli
, et al.
·
Journal of Clinical Oncology
·
168
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.
1998
·
M Lopez
, P Vici
, et al.
·
Journal of Clinical Oncology
·
139
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
1995
·
C Botti
, P Vici
, et al.
·
PubMed
·
54
Evaluation of nilotinib in advanced GIST previously treated with imatinib and sunitinib
2011
·
C. Cauchi
, N. Somaiah
, et al.
·
Cancer Chemotherapy and Pharmacology
·
52
PDF
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a
1995
·
E. Garaci
, M. Lopez
, et al.
·
European Journal of Cancer
·
43
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
2000
·
E. Maiello
, V. Gebbia
, et al.
·
Annals of Oncology
·
34
PDF
Biochemotherapy with thymosin α1, interleukin-2 and dacarbazine in patients with metastatic melanoma: Clinical and immunological effects
1994
·
M. Lopez
, F. Ameglio
, et al.
·
Annals of Oncology
·
34
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)
2006
·
E. Maiello
, F. Giuliani
, et al.
·
Annals of Oncology
·
31
PDF
Scriptaid effects on breast cancer cell lines
2011
·
L. Giacinti
, C. Giacinti
, et al.
·
Journal of Cellular Physiology
·
30
[Gemcitabine in advanced stage soft tissue sarcoma: a phase II study].
1999
·
A Amodio
, S Carpano
, et al.
·
PubMed
·
28
Inhibition of NADH-linked respiration with the anti-cancer agent 4′-demethyl-epipodophyllotoxin thenylidene glucoside (VM-26)
1972
·
Mario Gosalvez
, J. Perez-Garcia
, et al.
·
European Journal of Cancer (1965)
·
28
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)
2005
·
E. Maiello
, V. Gebbia
, et al.
·
Annals of Oncology
·
26
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer
2005
·
L. Di Lauro
, F. Belli
, et al.
·
Annals of Oncology
·
18
PDF
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
2007
·
L Di Lauro
, C Nunziata
, et al.
·
British Journal of Cancer
·
16
PDF
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
2011
·
P. Vici
, M. Brandi
, et al.
·
Annals of Oncology
·
15
Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: Clinical and immunological effects
1995
·
M. Lopez
, L. Di Lauro
, et al.
·
Annals of Oncology
·
14
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer
1995
·
M. Lopez
, P. Vici
, et al.
·
European Journal of Cancer
·
13
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma
1993
·
M. Lopez
, S. Carpano
, et al.
·
Annals of Oncology
·
12
Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
2008
·
P Vici
, G Viola
, et al.
·
PubMed
·
7
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
2008
·
P Vici
, G Viola
, et al.
·
PubMed
·
7
A Review of its Pharmacological Properties and Clinical Efficacy in the Treatment of Haematological Malignancies and Advanced Breast Cancer
1997
·
Axel Glasmacher
, M López
, et al.
·
5
111In-octreotide scintigraphy in small cell lung cancer.
1995
·
A Semprebene
, A Ferraironi
, et al.
·
PubMed
·
3
Clinical Modulation of Epirubicin Resistance by Lonidamine in Patients With Advanced Soft-tissue Sarcomas
1995
·
M LOPEZ
, S CARPANO
, et al.
·
International Journal of Oncology
·
3
[Merkel cell carcinoma].
2006
·
G Viola
, P Visca
, et al.
·
PubMed
·
2
Toxicity of epirubicin and cyclophosphamide (EC) vs. docetaxel (D) followed by EC in the adjuvant (adj) treatment of node positive breast cancer. A multicenter randomized phase III study (GOIM9902)
2006
·
M. Lopez
, M. Brandi
, et al.
·
Journal of Clinical Oncology
·
2
Show more works
View as search
Works count:
48
Citation count:
791
H-index:
15
I10-index:
18
Year
Topic
Type